PC}: Karissa L flacketlon Appoirimnent Predity: CPC Weadham 07/30/2024 Lauren Bronner Reason for Appointment i. Ft transfer 2. Med refills History of Present Illness Depression Screening: PHO-9 Little interest or pleasure in doing things Not at all Feeling down, depressed, or hopeless Not at all Trouble falling or staying asleep, or sleeping too much Not at all Feeling tired or having little energy Not at all Poor appetite or overeating Not at ail Feeling bad about yourself or that you are a failure, or have let yourself or your family down Not at all Trouble concentrating on things, such as reading the newspaper or watching television Not at ail Moving or speaking so slowly that other people could have noticed; or the opposite, being so fidgety or restless that you have been moving around a lot more than usual Not at all Thoughts that you would be better off dead or of hurting yourself in some way Not at all Total Score o History: 59-year-old female with history of hypothyroidism, insomnia, anxiety presenting for medication review and refills. Patient takes 25 mg of trazodone for sleep nightly, hopes to wean off this. Feels her mood overall is stable on current medication regimen. Of note, patient had a hospitalization in April 2024 for bilateral frontoparietal craniotomies for chronic subdural hematomas. This was found on MRI of brain following a head trauma 2 months prior. Patient had been having extreme headaches and dizziness. During this time patient was also placed on Keppra for seizure prophylaxis as well as amlodipine for high blood pressure, she is off both of these now. Patient has residual hand weakness and continues to work with occupational therapy. She is back to regular exercise however still cannot hold weights or hold a tennis racquet due to her weakness. Dr, Alexander Neurological Associates. Current Medications Taking * « * « Flonase 50 MCG/ACT Suspension 2 sprays in each nostril Nasally Once a day Mucinex 600 MG Tablet Extended Release 12 Hour 1 tablet as needed Orally every iz hrs Hair Skin Nafis « Capsule as directed Orally traZODone HCl 50 MG Tablet1 tablet at bedtime as needed Orally Once a day , Notes to Pharmacist: 1/2 tab DULoxetine HCI 60 MG Capsule Delayed Release Particles take one capsule by mouth one time daily Orally Onee a day , Notes to Pharmacist: LAST FILL KEEP UPCOMING APPT Synthroid 112 MCG Tablet 1 tablet Orally Once a day , Notes to Pharmacist: BRAND ONLY! vaACYclovir HC] 500 MG Tablet TAKE ONE TABLET BY MOUTH ONE TIME DAILY Oral Progress Note: Lauren Brunner 07/30/2024 SATE pea she 1" REUSE eye Tekh EE MOSM (Serva eel, GP eee Geek Generated for Frinting/Faxing/eTranamitting on: 08/03/2024 02:23 PM EDT 1/30
Hemoglobin 12.5 12.4 12.7 LLO 13.0 (Ref (Ref (Ref (Ref (Ref Range: Range: Range: Range: Range: ; 11.§-16.0 11.9°16.0 11.5°16.0 11.9-16.0 11.5~16.0 g/dL) g/dl) g/dl) = g/d) ~— g/L) Hematocrit 38.4 36.5 38.5 35.5 38.9 (Ref (Ref (Ref (Ref (Ref Range: Range: Range: Range: Range: 35.0°47.0 35.0-47.0 35.0°47.0 35.0°47.0 35,.0-47.0 nome ee Lene eee» : %6) %6) %6) %) %6) ' “Platelet 233 233 229 219 240 Count (Ref (Ref (Ref (Ref (Ref Range: Range: Range: Range: Range: 130-400 130-400 130-400 130-400 130-400 K/uL) K/uL) K/ub) K/uL) K/al) ; RDW-CV% 12.8 12,7 12.7 12,5 13.8 (Ref (Ref (Ref (Ref (Ref Range: Range: Range: Range: Range: W,5-14.5 115-145 11.5-14.5 5-145 11.9+14.5 %) %) %) %) %) * Mev 91.6 91.7 93.0 94.4 93.1 (Ref (Ref {Ref (Ref (Ref Range; Range: Range: Range: Range: 80.0-99.0 B0.0-99.0 80.0+99,0 80.0°99.0 80.0~99.0 fL) fL) fL) fL) fl} ; MCH 29.8 31.2 30.7 31.6 31.1 (Ref (Ref (Ref (Ref (Ref Range: Range: Range: Range: Range: 26.0-34.0 26.0-34.0 26.0-34.0 26.0-34.0 26,0-34.0 / pg) pg) pg) pg) pg) : MCHC 32.6 34.0 33.0 33.5 33.4 (Re (Ref (Ref (Ref (Ref Range: Range: Range: Range: Range: i 31.0°35,0 31,0°35.0 31,0-35.0 31,0-35.0 31.0-35.0 g/dL} g/dl) g/dl) g/dl) = g/dL) ' Lymphocyte 30.2 31.5 37.5 38.4 29.0 8% (Ref (Ref (Ref (Ref . (Ref Range: Range: Range: Range: Range: VW74-5L7 UPA GU 174-517 17.4°517 — 17.4°§1.7 %) %) %) %) 7) ' Mono% 6.8 8.3 6.6 7.0 5.3 (Ref (Ref (Ref (Ref (Ref Range: 4.5- Range: 4,5- Range: 4.5- Range: 4.5-Range: 4.5- 12.5%) 125%) 12.5%) 125%) 12.5%) EOS% 2.6 2.3 3.1 2.5 2.0 (Ref (Ref (Ref (Ref (Ref i Range; 0.5-Range: 0.5-Range: 0.9-Range: 0.5-Range: 0.5- 58%) 5.8%) §.8%) §8%) 5.8%) tencnwnce Ninteas Dauta ft Bahinean WMM nael/aRl/nana
emist lum otassium oride - roon Dioxide ion Ga - - m reatinine (0.55 - 1.02 m stim Creat Clear c (mL/min st > mL/min ucose cium ematolo t mmature Gran eut uto uto no O Os uto uto ucleat eut O m uto no uto Os uto aso uto) (0.00 - mmature Gran uto ute Nucleat Page 8 of 10
Order Date: 04/03/24 —Service— Category Procedure Name Order Number Date Time Pri Qty Ord Source Status Ordered By LAB CBC W/O DIFF 20240404-0245 04/04/24 0400 R E CMP GILRI1 Other Provider : Sig Lvl Provider : Order’s Audit Trail of Events 04/03/24 1553 AP.GILRI Order ENTER in POM 04/03/24 1553 AP.GILRI Ordering Doctor: Gilliam,Richard R NP 04/03/24 1553 AP.GILRI Order Source: EPOM Chee g ; 6 04/04/24 0001 interface cc'd doctors edited in LAB i 04/04/24 0001 interface order’s status changed from TRANS to LOGGED by LAB 8 04/04/24 0611 interface order’s status changed from LOGGED to IN PRO by LAB 9 04/04/24 0616 interface order’s status changed from IN PRO to COMP by LAB Order Date: 04/03/24 —Service— Category Procedure Name Order Number Date Time Pri Qty Ord Source Status Ordered By LAB BASIC METABOLIC PROF W/REFLEX 20240404-0246 04/04/24 0400 R E CMP GILRI1 Other Provider : Sig Lv] Provider : Order’s Audit Trail of Events 1 04/03/24 1553 AP.GILRI Order ENTER in POM 2 04/03/24 1553 AP.GILRI Ordering Doctor: Gilliam,Richard R NP 3 04/03/24 1553 AP.GILRI Order Source: EPOM a Grea 5 04/03/24 1623 3BAZ0038 order acknowledged 6 04/04/24 0001 interface cc’d doctors edited in LAB 7 04/04/24 0001 interface order’s status changed from TRANS to LOGGED by LAB 8 04/04/24 0611 interface order’s status changed from LOGGED to IN PRO by LAB 9g 04/04/24 0634 interface order’s status changed from IN PRO to COMP by LAB Order Date: 04/03/24 —Service— Category Procedure Name Order Number Date Time Pri Qty Ord Source Status Ordered By MED.COCHR MULTIDOSE MEDICATIONS 20240404-0656 04/04/24 0600 R IZ CMP OSBER Other Provider: Sig Lvl Provider : DCECDMANCNT MENTAL DECTNDN CNODV
Order Date: 04/04/24 —Service— Category Procedure Name Order Number Date Time Pri Qty Ord Source Status Ordered By NUR.PHYS Discharge Criteria 20240404-0494 04/04/24 0925 E IPR WILDA4 Other Provider : Sig Lvl] Provider: Press (ENTER) for Order Details below Comment : D/C PT FROM PACU WHEN CRITERIA MET Order’s Audit Trail of Events 04/04/24 0925 DR.WILDA4 Order ENTER in POM 04/04/24 0925 DR.WILDA4 Order from set: PACU Adult 04/04/24 0925 DR.WILDA4 Ordering Doctor: Williams,David G.A. MD 04/04/24 0925 DR.W : 04/04/24 0925 interface order's status changed from TRANS to ACTIVE by NUR 04/04/24 1313 3NNI9254 order acknowledged 04/06/24 1652 DR.KOHJA1 Order marked to be continued upon patient. transfer 6/24 2055 PWSNS 04/06/24 2055 PWSNS10 Ordering Doctor: Kohout, Jaromir MD 04/06/24 2055 PWSNS10 Order Source: EPOM 04/06/24 2055 PWSNS10 Order continued upon patient transfer. 04/06/24 2058 PWSNS10 order acknowledged Order Date: 04/04/24 ——Service— Category Procedure Name Order Number Date Time Pri Qty Ord Source Status Ordered By NUR.PHYS Notify MD 20240404-0495 04/04/24 0925 E IPR WILDA4 Other Provider : Sig Lvl Provider : Press (ENTER) for Order Details below Comment : Notify provider of HH results if ordered Order’s Audit Trail of Events 1 04/04/24 0925 DR.WILDA4 Order ENTER in POM 2 04/04/24 0925 DR.WILDA4 Order from set: PACU Adult 3 04/04/24 0925 DR.WILDA4 Ordering Doctor: Williams,David G.A. MD 4 Order Source: EPOM order’s status changed from TRANS to 7 04/04/24 1313 3NNI9254 order acknowledged 04/06/24 1652 DR.KOHJA1 Order marked to be continued upon patient trans 4/06/24 2055 PWSNS10 Order RECEIVE in NUR 11 04/06/24 2055 PWSNS10 Ordering Doctor: Kohout,Jaromir MD 12. 04/06/24 2055 PWSNS10 Order Source: EPOM 13 04/06/24 2055 PWSNS10 Order continued upon patient transfer. PERMANENT MEDICAL RECORD COPY
is/Problem/Outcome/Care Item Description
